Medical Devices Startups

AI-powered clinical documentation platform that automatically generates notes, charts, and referrals from dental office conversations using ambient voice technology. The solution serves dental practices and DSOs (Dental Service Organizations) to reduce administrative workload and standardize clinical records.

1 investor

Dental Iberica is an online supplier of dental products for dentists and dental laboratories, offering clinic consumables, instruments, prosthetics, orthodontics, endodontics, and equipment such as lamps, autoclaves, scanners and compressors. It also sells its own ID Premium brand items and distributes third-party brands, serving the Spanish and Portuguese markets.

1 investor

DentalMonitoring offers an AI platform that analyzes smartphone-captured intraoral images to detect and report on 130 oral events, assisting dental professionals with remote observation and monitoring of orthodontic treatments. The product is designed for Healthcare Professionals and used by patients under their supervision, with some modules registered as CE-marked medical devices.

1 investor

Denti.AI develops artificial intelligence technology for teeth pathology detection and clinical applications in dentistry. The company serves dental practices, dental school operators (DSOs), and dental professionals seeking diagnostic and workflow solutions powered by deep learning.

1 investor

Dentius operates a network of multidisciplinary dental clinics across Belgium and the Netherlands, emphasizing preventive care, patient-centered treatment, and natural tooth preservation. The organization manages over 100 clinics focused on quality dental services and transparent patient communication.

1 investor

DentoAI provides AI-powered documentation and workflow automation for dental practices, using passive voice recording during patient consultations to generate clinical notes and reduce administrative burden. The platform helps dental professionals focus on patient care while automating documentation tasks like chart notes and referral letters.

1 investor

OralFitnessCheck is a chairside oral wellness test for dental practices that measures the aMMP-8 biomarker from a 30-second saliva swish and produces an Oral Fitness Score in about five minutes using the Oralyzer analyzer. It is aimed at dentists and hygiene teams to support proactive periodontal care and patient engagement.

1 investor

Implantly provides full mouth dental implant solutions across the UK, offering single, multiple, and full arch implants with advanced 3D planning and guided surgery techniques. The company partners with selected UK clinics to deliver affordable dental restoration services for patients seeking to replace missing teeth.

1 investor

DePuy Synthes develops orthopedic medical devices and solutions including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery, and sports medicine products, along with digital surgery technologies. The company serves surgeons and healthcare institutions performing orthopedic procedures.

1 investor

DermaScan operates health spaces staffed by nurses and general practitioners that provide skin cancer screening and mole surveillance consultations, prioritizing patients referred by doctors or with high risk factors. Appointments are booked via Doctolib, and consultations are partially reimbursed by French health insurance.

1 investor

DermaSensor develops healthcare technology for skin cancer detection, serving physicians and patients in the medtech sector.

1 investor

Dermavision Solutions builds Deviskan, an automated device that combines total body mapping and digital dermoscopy to capture full-body clinical images and support dermatologists in patient monitoring and early melanoma detection. The company serves dermatology clinics and hospitals across Europe with a CE-certified medical device.

1 investor

DermR Health is a healthcare startup focused on improving how skin cancer is managed, aiming to reduce unnecessary skin biopsies for benign lesions. The company is currently raising a seed round.

1 investor

Detective Biosciences is developing a blood-based cancer detection test that analyzes patients' DNA epigenetic profiles. The company operates in the cancer diagnostics and biotech space.

1 investor

Detraxi is a privately held company developing emerging technology, seeking development funding and licensing partnerships. The page provides limited detail about the specific product or industry.

1 investor

DeuterOncology is a clinical-stage biotech developing DO-2, a deuterated, brain-penetrant MET kinase and RAS pathway inhibitor for cancer patients, currently in a phase 1 clinical study. The molecule was in-licensed from OCTIMET Oncology and originally from Janssen Pharmaceutica.

1 investor

Develo builds an AI-native, FHIR-conformant software platform for independent pediatric practices that combines charting, billing, practice management, and family engagement in one system. The company positions its product as an end-to-end alternative to traditional EMRs, serving pediatricians in the US.

1 investor

A distributor or reseller of robotic surgical systems, including the da Vinci and Symani systems, that supports hospitals and surgical centers in Australia with robotic-assisted surgical technology and implementation.

1 investor

Dexcom develops continuous glucose monitoring (CGM) systems and glucose biosensors, including the Dexcom G7 and the over-the-counter Stelo biosensor, that send real-time glucose readings to a phone or receiver. Its products serve people managing diabetes as well as consumers tracking glucose for general health, diet, and exercise.

1 investor

Dexter Magnetic Technologies develops and manufactures magnetic solutions and components for industrial applications. The company serves diverse industries through engineering and quality-focused product offerings.

1 investor

DiabeTech develops an AI-powered biosensor sock and mobile platform to detect diabetic foot complications and ulcers at an early stage, serving patients and healthcare providers. The company operates in the digital health and medical device space, partnering with healthcare systems and clinics across the United States.

1 investor

ModalityDx develops quantitative point-of-care diagnostic tests using molecular biomarkers and data science to detect and assess treatment response for diseases including diabetes, maternal health conditions, and autoimmune disorders. The company also supports pharmaceutical firms in drug development and therapeutic efficacy assessment.

1 investor

Diadem Bio develops therapeutic treatments designed to be safe, powerful, versatile and cost-effective for patients with unmet medical needs, with a focus on potential cancer cures and other difficult diseases.

1 investor

Diadem is a diagnostics company developing AlzoSure, a plasma/blood-based test that uses a proprietary antibody targeting a specific conformation of the p53 protein to predict and diagnose Alzheimer's disease. The test aims to provide early, non-invasive diagnosis and to support patient recruitment for Alzheimer's drug development clinical trials.

1 investor